{"topic_id":"ade_mepivacaine_adverse_events","category":"ade","context":"---\ntopic_id: ade_mepivacaine_adverse_events\ncategory: ade\ntitle: \"FDA ADE reports for Mepivacaine Hydrochloride (active ingredient) — total reports, species & reaction breakdown\"\nlang: en\nsource: \"openFDA animalandveterinary/event.json (FDA CVM adverse event reports), pulled 2026-07-22\"\nsource_file: pdf-raw/ade/ade_active_ingredients_2026-07-22_b25.json\ndate_parsed: 2026-07-22\ntokens_estimated: 392\nverification:\n  method: substring_match\n  claims: 34\n  passed: 34\n  date: 2026-07-22\n---\n\n# Mepivacaine Hydrochloride — FDA Animal & Veterinary Adverse Event (ADE) Reports\n\nSource: openFDA `animalandveterinary/event.json`, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Mepivacaine Hydrochloride is a active ingredient.\n\n## Total reports\nMepivacaine Hydrochloride: 47\n\n## Reports by species (top entries)\n- Horse 33\n- Dog 4\n- Cat 2\n- Cattle 1\n- Human 1\n- Mule 1\n\n## Top reported reactions (VEDDRA terms, top entries)\n- INEFFECTIVE, ANESTHESIA 10\n- Ataxia 5\n- Death by euthanasia 5\n- Bradycardia 3\n- Collapse (see also 'Cardio-vascular' and 'Systemic disorders') 3\n- Fever 3\n- Hind limb paresis 3\n- INEFFECTIVE, ANALGESIA 3\n- Joint swelling 3\n- Lameness 3\n\nSource JSON: `pdf-raw/ade/ade_active_ingredients_2026-07-22_b25.json` (openFDA animalandveterinary/event.json, pulled 2026-07-22).\n","sources":[],"tokens_estimated":252,"generated_at":null,"tip":"Use /api/v1/topics to discover more topics. /api/v1/nutrient for precise single-point queries. /api/v1/cross_compare for 2-3 standard comparisons."}